Toremotsa, Efefania P.

HRN: 26-95-50  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/09/2026
04/16/2026
IV
4.5g
Q6
Abscess
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines